Literature DB >> 21480927

Pollen proteases compromise the airway epithelial barrier through degradation of transmembrane adhesion proteins and lung bioactive peptides.

R Vinhas1, L Cortes, I Cardoso, V M Mendes, B Manadas, A Todo-Bom, E Pires, P Veríssimo.   

Abstract

BACKGROUND: Allergic disorders, such as seasonal rhinitis and asthma, are increasing causes of morbidity worldwide and often result from exposure to airborne pollen. Pollen allergy has a remarkable clinical impact all over Europe. In fact, epidemiological longitudinal studies confirm that pollen species usually considered with low allergenic potential became more recently responsible for intense allergic reactions. In this study, we aimed to characterize major pollen proteolytic activity and evaluate its contribution to the immunologic and inflammatory response to airborne allergens.
METHODS: Proteolytic activity in four pollen diffusates with distinct allergenicity, Olea europaea, Dactylis glomerata, Cupressus sempervirens and Pinus sylvestris, was evaluated through several enzymatic assays. The action of pollen proteases on the paracellular integrity of Calu-3, grown at the air-liquid interphase, was evaluated through a transepithelial permeability assay. Immunoblot and immunofluorescence experiments were performed to analyse the disruption of intercellular complexes. Degradation of bioactive peptides by pollen crude extracts was assessed by mass spectrometry.
RESULTS: All pollen diffusates were shown to have high molecular weight proteases with serine and/or aminopeptidase activity. These proteases increased Calu-3 transepithelial permeability through disruption of transmembrane adhesion proteins: occludin, claudin-1 and E-cadherin. Moreover, they were able to degrade airway bioactive peptides and were not blocked by endogenous protease inhibitors.
CONCLUSION: Pollen grains with distinct allergenic abilities release proteases that might be involved in the sensitization to a range of airborne allergens by facilitating allergen delivery across the epithelium and also contribute directly to the inflammation characteristic of allergic diseases.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21480927     DOI: 10.1111/j.1398-9995.2011.02598.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  39 in total

Review 1.  Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.

Authors:  Lila G Glotfelty; Gail A Hecht
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

Review 2.  Danger-Associated Molecular Patterns (DAMPs): the Derivatives and Triggers of Inflammation.

Authors:  Seema Patel
Journal:  Curr Allergy Asthma Rep       Date:  2018-09-28       Impact factor: 4.806

3.  Modulation of airway epithelial antiviral immunity by fungal exposure.

Authors:  Lingxiang Zhu; Boram Lee; Fangkun Zhao; Xu Zhou; Vanessa Chin; Serena C Ling; Yin Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

4.  Microtubules are required for efficient epithelial tight junction homeostasis and restoration.

Authors:  Lila G Glotfelty; Anita Zahs; Catalin Iancu; Le Shen; Gail A Hecht
Journal:  Am J Physiol Cell Physiol       Date:  2014-06-11       Impact factor: 4.249

Review 5.  Airway epithelial barrier dysfunction in the pathogenesis and prognosis of respiratory tract diseases in childhood and adulthood.

Authors:  Hasan Yuksel; Ahmet Turkeli
Journal:  Tissue Barriers       Date:  2017-09-08

Review 6.  Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases.

Authors:  Robert P Schleimer; Sergejs Berdnikovs
Journal:  J Allergy Clin Immunol       Date:  2017-06       Impact factor: 10.793

Review 7.  Innate responses to pollen allergens.

Authors:  Koa Hosoki; Istvan Boldogh; Sanjiv Sur
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-02

8.  Establishing a liquid-covered culture of polarized human airway epithelial Calu-3 cells to study host cell response to respiratory pathogens in vitro.

Authors:  Jennifer L Harcourt; Lia M Haynes
Journal:  J Vis Exp       Date:  2013-02-07       Impact factor: 1.355

Review 9.  Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation.

Authors:  Steve N Georas; Fariba Rezaee
Journal:  J Allergy Clin Immunol       Date:  2014-07-29       Impact factor: 10.793

Review 10.  Role of Environmental Adjuvants in Asthma Development.

Authors:  Donald N Cook
Journal:  Curr Allergy Asthma Rep       Date:  2020-06-16       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.